Tiapride hydrochloride

This classification denotes an anti-dyskinesia agent C15H24N2O4S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 25N106WEDO, chemically known as benzamide, n-(2-(diethylamino)ethyl)-2-methoxy-5-(methylsulfonyl)-, hydrochloride (1:1), but more generally known as tiapride hydrochloride, which bears US NIH Compound Identifier 5702214. European Medicines Agency schedules Tiapride hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04854MIG. Most nations, for tariff and trade purposes, schedule tiapride hydrochloride under HS 29242995 and SITC 51479. As of Q4 2014, TIAPRIDE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CCN(CC)CCNC(=O)C1CC(CCC1OC)S(=O)(=O)C.CL.